Patents by Inventor Philippe A. Tessier

Philippe A. Tessier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating rheumatoid arthritis using anti-S100A9 antibody
    Patent number: 8282925
    Abstract: The present invention relates to compounds and methods for modulating, reducing or inhibiting, inflammatory reactions in a patient. Particularly, inflammatory reactions that are targeted by the present invention are cell migration, secretion of toxic products and proteolysis at a site of inflammation. Reduction of inflammation manifestations and reactions occurs by using an anti-S100 polynucleotide or polypeptide inhibitor or antagonist, which is essentially targeted against S100A8, S100A9 or S100A12, alone or in combination with other inhibitors of chemokines or immune modulating products.
    Type: Grant
    Filed: May 21, 2009
    Date of Patent: October 9, 2012
    Assignee: Universite Laval
    Inventors: Philippe A. Tessier, Carle Ryckman, Karen Vandal, Pascal Rouleau
  • COMPOUNDS AND METHOD FOR MODULATING INFLAMMATORY REACTIONS
    Publication number: 20090275516
    Abstract: The present invention relates to compounds and methods for modulating, reducing or inhibiting, inflammatory reactions in a patient. Particularly, inflammatory reactions that are targeted by the present invention are cell migration, secretion of toxic products and proteolysis at a site of inflammation. Reduction of inflammation manifestations and reactions occurs by using an anti-S100 polynucleotide or polypeptide inhibitor or antagonist, which is essentially targeted against S100A8, S100A9 or S100A12, alone or in combination with other inhibitors of chemokines or immune modulating products.
    Type: Application
    Filed: May 21, 2009
    Publication date: November 5, 2009
    Inventors: Philippe A. TESSIER, Carle RYCKMAN, Karen VANDAL, Pascal ROULEAU
  • Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions
    Patent number: 7553488
    Abstract: The present invention relates to compounds and methods for modulating, reducing or inhibiting, inflammatory reactions in a patient. Particularly, inflammatory reactions that are targeted by the present invention are cell migration, secretion of toxic products and proteolysis at a site of inflammation. Reduction of inflammation manifestations and reactions occurs by using an anti-S100 polynucleotide or polypeptide inhibitor or antagonist, which is essentially targeted against S100A8, S100A9 or S100A12, alone or in combination with other inhibitors of chemokines or immune modulating products.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: June 30, 2009
    Assignee: Université Laval
    Inventors: Philippe A. Tessier, Carle Ryckman, Karen Vandal, Pascal Rouleau